Uk Mhra Gmp
CADILA PHARMACEUTICALS LIMITEDCADILA PHARMACEUTICALS LIMITED – UK MHRA GMP Certificate UK GMP 20872 Insp GMP 20872/14013-0008[H]
Record Details
This Uk Mhra Gmp record concerns CADILA PHARMACEUTICALS LIMITED, with an inspection on December 11, 2023, issued by the MHRA, covering drugs.
- Compliance status
- GMPC
- Certificate type
- GMP
- Inspection date
- December 11, 2023
- Issued
- March 15, 2024
- MIA number
- UK GMP 20872
- Site address
- PLOT NO. 1389 TRASAD ROAD, DHOLKA, AHMEDABAD, IN 382225, INDIA
- Country
- INDIA
- Products
- Human Medicinal Products
- Manufacturing operations
- 1. MANUFACTURING OPERATIONS [ 1.2 ] Non-sterile products [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) [ 1.2.1.1 ] Capsules, hard shell [ 1.2.1.13 ] Tablets [ 1.5 ] Packaging [ 1.5.1 ] Primary packaging [ 1.5.1.1 ] Capsules, hard shell [ 1.5.1.13 ] Tablets [ 1.5.2 ] Secondary packaging [ 1.6 ] Quality control testing [ 1.6.2 ] Microbiological: non-sterility [ 1.6.3 ] Chemical/Physical
- Restrictions
- The inspection only covered non-sterile products manufactured in the Main Pharmaceutical Building. It did not cover the manufacture of B-lactams, cephalosporins, rifampicin or insulin, which were manufactured in other buildings on the site. Any restrictions related to the scope of this certificate: Restrictions Building Room Line/equipment QC Testing Products The inspection only covered non-sterile products manufactured in the Main Pharmaceutical Building. It did not cover the manufacture of B-lactams, cephalosporins, rifampicin or insulin, which were manufactured in other buildings on the site.
View Company Profile
ID · 570885fe-8c98-41e4-9c9d-0f4db183359b
Other documents for CADILA PHARMACEUTICALS LIMITED
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.